Vector Capital Announces Successful Completion of Cash Tender Offer for Shares of Sizmek
Sep 27, 2016 12:24 pm UTC| Business
AUSTIN, Texas, Sept. 27, 2016 -- Sizmek Inc. (NASDAQ:SZMK) (the “Company” or “Sizmek”) and Vector Capital (“Vector”) today announced the successful completion of the tender offer (the “Offer”) by Solomon Merger...
Sep 27, 2016 12:19 pm UTC| Business
Dublin, Sept. 27, 2016 -- Research and Markets has announced the addition of the "Caps and Closures Market in North America 2016-2020" report to their offering. The caps and closures...
Sep 27, 2016 12:15 pm UTC| Business
Albany - New York, Sept. 27, 2016 -- A new Transparency Market Research report states that the global clinical trial management system (CTMS) market was valued at US$844 mn in 2013 and is predicted to reach US$1,848.5...
Sep 27, 2016 12:05 pm UTC| Business
-- Complete Tumor Regression Seen in 80% of Animals Treated with Triple Combination of PS-Targeting Antibody, Anti-PD-1 Therapy and Anti-Lag3 Therapy vs. 0% of Animals Receiving Double Anti-PD-1/Anti-Lag3 Treatment...
Companion Diagnostics Market worth 5.58 Billion USD by 2019; Transparency Market Research
Sep 27, 2016 12:04 pm UTC| Business
Albany – New York, Sept. 27, 2016 -- The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to 2019 to reach US$5.58 bn by 2019. The market was worth US$2.80 bn in 2015. North America is projected...
RedHill Biopharma to Present at the BioNetwork West 2016 Partnering Summit
Sep 27, 2016 12:02 pm UTC| Business
TEL-AVIV, Israel, Sept. 27, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
RedHill Biopharma to Present at the BioNetwork West 2016 Partnering Summit
Sep 27, 2016 12:02 pm UTC| Business
TEL-AVIV, Israel, Sept. 27, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...